Bioactivities of N-(4-hydroxyphenyl) retinamide and retinoyl β- glucuronide

FASEB Journal

Volumn 10, Issue 9, 1996, Pages 1014-1024

  Formelli, Franca ^a   Barua, Arun B ^b   Olson, James Allen ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

4HPR; cancer; cell; differentiation; RAG; toxicity; glucuronide

Indexed keywords

DRUG METABOLITE; FENRETINIDE; PLACEBO; RETINOIC ACID; RETINOIC ACID DERIVATIVE; RETINOIC ACID GLUCURONIDE; RETINOL; UNCLASSIFIED DRUG;

ACNE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BREAST CARCINOMA; CANCER CELL CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG SYNTHESIS; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MOUSE; NIGHT BLINDNESS; NIGHT VISION; NONHUMAN; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAT; RETINOL DEFICIENCY; REVIEW; SKIN TOXICITY; TERATOGENICITY; TOPICAL DRUG ADMINISTRATION;

EID: 0029816269     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.10.9.8801162     Document Type: Review

References (109)

1. Sporn, M. B., Roberts, A. B., and Goodman, D. S., eds (1994) The Retinoids: Biology, Chemistry, and Medicine, 2nd Ed, pp. 1-679, Raven Press, New York
2. Olson, J. A. (1994) Vitamin A, retinoids and carotenoids. In Modern Nutrition in Health and Disease, 8th Ed (Shils, M. E., Olson, J. A., and Shike M., eds) pp. 178-209, Lea & Febiger, Philadelphia
3. Bollag, W., and Matter, A. (1981) From vitamin A to retinoids in experimental and clinical oncology: achievements, failures, and outlook. Ann. N.Y. Acad. Sci. 359, 9-23
4. Dawson, M. I., and Hobbs, P. D. (1994) The synthetic chemistry of retinoids. In The Retinoids (Sporn, M. B., Roberts, A. B., and Goodman, D. S., eds) 2nd Ed, pp. 5-178, Raven Press, New York
5. Gander, R. J., and Gurney, J. A. (1978) All-trans retinoic acid esters and amides. U.S. patent 4,108,880, August 22, 1978; Chem. Abstr. 88, 89892
6. Moon, R. C., Thompson, H. J., Becci, P. J., Grubbs, C. J., Gander, R. J., Newton, D. L., Smith, J. M., Phillips, S. L., Henderson, W. R., Mullen, L. T., Brown, C. C., and Sporn, M. B. (1979) N-(4-hydroxyphenyl)retinamide, a new retinoid for the prevention of breast cancer in the rat. Cancer Res. 39, 1339-1346
7. Barua, A. B., and Olson, J. A. (1985) Preparation of retinamides by use of retinoyl fluoride. J. Lipid Res. 26, 258-262
8. Panigot, M. J., Humphries, K. A., and Curley, R. W. (1994) Preparation of 4-retinamidophenyl- and 4-retinamidobenzyl-C-glycosyl and C-glucuronosyl analogues of the glucuronide of 4-hydroxyphenyl-retinamide as potential stable cancer chemopreventive agents. J. Carbohydrate Chem. 13, 303-321
9. Furr, H. C., Barua, A. B., and Olson, J. A. (1994) Analytical methods. In The Retinoids (Sporn, M. B., Roberts, A. B., and Goodman, D. S., eds) 2nd Ed, pp. 179-209, Raven Press, New York
10. Barua, A. B., and Olson, J. A. (1985) Chemical synthesis uf all-trans retinoyl β-glucuronide. J. Lipid Res. 26, 1277-1282
11. 3H]-retinoyl β-glucuronide in its metabolism in rats in vivo. Biochem. J., 263, 403-409
12. Barua, A. B. (1990) Analysis of water-soluble compounds: glucuronides. Methods Enzymol 189, 136-145
13. Becker, B., Barua, A. B., and Olson, J. A. (1996) All-trans retinoyl β-glucuronide: new procedure for chemical synthesis and its metabolism in vitamin A-deficient rats. Biochem. J. 314, 249-252
14. Barua, A. B., Huselton, C., and Olson, J. A. (1996) Synthesis of novel glucuronide conjugates of retinoid carboxylic acids. Synth. Commun. 26, 1355-1361.
15. Biesalski, H. K., Doepner, G., and Gerharz, C. D. (1993) All-trans retinyland all-trans retinoyl-β-D-glucuronides: synthesis, pharmacology, and biological activity. In Retinoids (Livrea, M. A., and Packer, L., eds) pp. 329-339, Marcel Dekker, New York
16. Barua, A. B., and Olson, J. A. (1986) Retinoyl β-glucuronide: an endogenous compound of human blood. Am. J. Clin. Nutr. 43, 481-485
17. 3H-all-trans retinyl β-glucuronide in rats in vivo. Biochem. J. 252, 415-420
18. Li, S., Bush, E., Barua, A. B., and Huselton, C. (1996) Quantification of retinoyl β-glucuronides in rat urine by reverse phase HPLC with UV detection. J. Chromatogr. In press
19. Moon, R. C., Mehta, R. C., and Rao, K. V. M. (1991) Rctinoids and cancer in experimental animals. In The Retinoids: Biology, Chemistry, and Medicine. 2nd Ed. (Sporn, M. B., Roberts, A. B., and Goodman, D. S., eds) pp. 573-593, Raven Press, New York
20. Cohen, L. A., Epstein, M., Saa-Pabon, V., Mesohter, C., and Zang, E. (1994) Interactions between 4-HPR and diet in MNU-induced mammary tumorigenesis. Nutr. Cancer 21, 271-283
21. Scott Lucia, M., Anzano, M. A., Slayter, M. V., Anver, M. R., Green, D. M., Shrader, M. W., Logsdon, D. L., Driver, C. L., Brown, C. C., Peer, C. W., Roberts, A. B., and Sporn, M. B. (1995) Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinaimde, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate. Cancer Res. 55, 5621-5627
22. Pollard, M., and Luckert, P. H. (1991) The inhibitory effect of 4-hydroxyphenyl retinamide (4-HPR) on metastasis of prostate adenocarcinomaIII cells in Lobund-Wistar rats. Cancer Lett. 59, 159-163
23. Pienta, K. J., Nguyen, N. M., and Lehr, J. E. (1993) Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide. Cancer Res. 53, 224-226
24. Formelli, F., and Cleris, L. (1993) Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity. Cancer Res. 53, 5374-5376
25. Haraoui, B., Wilder, R. L., Allen, J. B., Sporn, M. B., Helfgott, R. K., and Brinkerhoff, C. E. (1985) Dose-dependent suppression by the synthetic retinoid, 4-hydroxyphenyl retinamide, of streptococcal cell wall-induced arthritis in rats. Immunopharmacology 7, 90-916
26. McCarthy, D. J., Lindamood, C., III, and Hill, D.L. (1987) Effects of retinoids on metabolizing enzymes and on binding of benzo(a)pyrene to rat tissue DNA. Cancer Res. 47, 5014-5020
27. Trizna, Z., Benner, S. E., Shirley, L., Furlong, C., and Hong, W. K. (1993) N-(4-hydroxyphenyl) retinamide is anticlastogenic in human lymphoblasloid cell lines. Anticancer Res. 13, 355-356
28. Sharma, S., Stutzman, J. D., Kelloff, G. J., and Steele, V. E. (1994) Screening of potential chemopreventive agents using biochemical markers of carcinogenesis. Cancer Res. 54, 5848-5855
29. Formelli, F., Clerici, M., Campa, T., Di Mauro, M. G., Magni, A., Mascotti, G., Moglia, D., De Palo, G., Costa, A., and Veronesi, U. (1993) Five-year administration of fenretinamide: pharmacokinetics and effects on plasma retinol concentrations. J. Clin. Oncol. 11, 2036-2042
30. Fontana, J. A. (1987) Interaction of retinoids and tamoxifen on the inhibition of human mammary carcinoma cell proliferation. Exp. Cell Biol. 55, 136-144
31. Marth, C., Bock, G., and Daxenbichler, C. (1985) Effect of 4-hytlroxyphenyl-retinamide and retinoic acid on proliferation and cell cycle of cultured human breast cancer cells. J. Natl. Cancer Inst. 75, 871-875
32. Pellegrini, R., Mariotti, A., Tagliabue, E., Bressan, R., Bunone, G., Coradini, D., Delia Valle, G., Formelli, F., Cleris, L., Radice, P., Pierotti, M. A., Colnaghi, M. I., and Menard, S. (1995) Modulation of markers associated with tumor aggressiveness in human breast cancer cell lines by N-(4-hydroxyphenyl)retinamide. Cell Growth & Differ. 6, 863-869
33. Sheikh, M. S., Shao, Z.-M., Li, Z.-S., Ordenez, J. V., Conley, B. A., Wu, S., Dawson, M. I., Man, O.-X., Chao, W., Quick, T., Niles, R. M., and Fonana, J. A. (1995) N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma. Carcinogenesis 16, 2477-2486
34. Igawu, M., Tanabe, T., Chodak, G. W., and Rukstails, D. B. (1994) N-(4-hydroxyphenyl) retinamide induces cell cycle specific growth inhibition in PC3 cells. Prostate 24, 299-305
35. Delia, D., Aiello, A., Lombardi, L., Pelicci, P. G., Grignani, F., Crignani, F., Formelli, F., Mvnnrcl, S., Costa, A., Veronesi, U., and Pierotti, M. A. (1993) N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including thuse unresponsive to retinoic acid. Cancer Res. 53, 6036-6041
36. Delia, D., Aiello, A., Formelli, F., Fontanella, E., Costa, A., Miyashita, T., Reed, J. C., and Pierotti, M. A. (1995) Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl)retinamide and effect of deregulated bcl-2. Blood 85, 359-367
37. Di Vinci, A., Geido, E., Infusini, E., and Giaretti, W. (1994) Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(4-hydroxyphenyl)relinamide. Int. J. Cancer 59, 422-426
38. Ponzoni, M., Bocca, P., Chiesa, V., Decensi, A., Pistoia, V., Raffaghello, K., Rozzo, C., and Montaldo, P. G. (1995) Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblasloma cells: apoptosis versus differentiation. Cancer Res. 55, 853-861
39. Supino, R., Crosti, M., Clerici, M., Warlters, A., Cleris, L., Zunino, F., and Formelli, F. (1996) Induction of apoplosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression. Int. J. Cancer 65, 1-7
40. Oridate, N., Lotan, D., Mitchell, M. F., Hong, W. K., and Lotan, R. (1995) Induction of apoptosis by retinoids in human cervical carcinoma cell lines. Int. J. Oncol. 7, 433-441
41. Kalemkerian, G. P., Slusher, R., Ramalingam, S., Gadgeel, S., and Mabry, M. (1995) Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines. J. Natl. Cancer Inst. 87, 1674-1600
42. Meyskens, F. L., Jr., Alberts, D. S., and Salmon, S. E. (1983) Effect of 13-cis-retinoic acid and 4-hydroxyphenyl-all-trans-retinamide on human tumor colony formation in soft agar. Int. J. Cancer 32, 295-299
43. Marth, Ch., Zech, J., Bock, G., Mayer, I., and Daxenbichler, C. (1987) Effects of retinoids and interferon-gamma on cultured breast cancer cells in comparison with tumor necrosis factor alpha. Int. J. Cancer 40, 840-845
44. Tubler, A., Dawson, M. I., and Koeffler, H. P. (1986) Retinoids. Structure-function relationship in normal and leukemic hematopoiesis in vitro. J. Clin. Invest. 78, 303-309
45. Sani, B. P., Shealy, Y. F., and Hill, D. L. (1995) N-(4-hydroxyphenyl)retinamide: interactions with retinoid-binding proteins/receptors. Carcinogenesis 16, 2531-2534
46. Swisshelm, K., Ryan, K., Lee, X., Tsou, H. C., Peacocke, M., and Sager, R. (1994) Down-regulation of retinoic acid receptor β in mammary carcinoma cell lines and its up-regululion in senescing normal mammary epithelial cells. Cell Growth & Differ. 5, 133-141
47. Malpeli, G., Stoppini, M., Zapponi, M. C., Folli, C., and Berni, R. (1995) Interactions with retinol and retinoids of bovine CRBP. Eur. J. Biochem. 229, 486-493
48. Swanson, B. N., Newton, D. L., Roller, P. P., and Sporn, M. B. (1981) Biotransformation and biological activity of N-(4-hydroxyphenyl)retinamide derivatives in rodents. J. Pharmacol. Exp. Ther. 219, 632-637
49. Bunk, M. J., Kinahan, J. J., and Sarkar, N. H . (1985) Biotransformation and protein binding of N-(4-hydroxyphenyl)retinamide in murine mammary epithelial cells. Cancer Lett. 26, 319-326
50. Mehta, R. G., Moon, R. C., Hawthorne, M., Formelli, F., and Costa, A. (1991) Distribution of fenretinide in the mammary gland of breast cancer patients. Eur. J. Cancer 27, 138-141
51. Professional staff, Johnson & Johnson Co. (1987) Fenretinide. Drugs Future 12, 305-306
52. Doose, D. R., Minn., F. L., Stellar, S., and Nayak, R. K. (1992) Effects of meals and meal composition on the bioavailability of fenretinide. J. Clin. Pharmacol. 32, 1089-1095
53. Peng, Y.-M., Dalton, W. S., Alberts, D. S., Xu, M.-J., Lim, H., and Meyskens, F. L. (1989) Pharmacokinetics of N-4-hydroxyphenyl-retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patients. Int. J. Cancer 43, 22-26
54. Formelli, F., Carsana, R., Costa, A., Buranelli, F., Campa, T., Dossena, G., Magni, A., and Pizzichetta, M. (1989) Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients. Cancer Res. 49, 6149-6152
55. Formelli, F., Carsana, R., and Costa, A. (1987) N-(4-hydroxyphenyl)retinamide (4-HPR) lowers plasma retinol levels in rats. Med. Sci. Res. 15, 843-844
56. Formelli, F., Clerici, M., De Palo, G., Costa, A., and Veronesi, U. (1991) Chronic oral administration of fenretinide, as a chemopreventive agent to breast cancer patients, does not affect plasma alpha-tocopherol concentration. Ann. Oncol. 2, 446-447
57. Kaiser-Kupfer, M. I., Peck, G. L., Caruso, R. C., Jaffe, M. J., DiGiovanna, J. J., and Gross, E. G. (1986) Abnormal retinal function associated with fenretinide, a synthetic retinoid. Arch. Ophthalmol. 104, 69-70
58. Kingston, T. P., Lowe, N. J., Winston, J., and Heckenlively, J. (1986) Visual and cutaneous toxicity which occurs during N-(4-hydroxyphenyl) retinamide therapy for psoriasis. Clin. Exp. Dermatol. 11, 624-627
59. Modiano, M. R., Dalton, W. S., Lippman, S. M., Joffe, L., Booth, A. R., and Meyskens, F. L., Jr. (1990) Phase II study of fenretinide (N-14-hy- droxyphenyl]retinamide) in advanced breast cancer and melanoma. Inv. New Drugs 8, 317-319
60. Berni, R., and Formelli, F. (1992) In vitro interaction of fenretinide with plasma retinol-binding protein and its functional consequences. FEBS Lett. 1, 43-45
61. Schaffer, E. M., Ritter, S. J., and Smith, J. E. (1993) N-(4-hydroxyphenyl)retinamide (Fenretinide) induces retinol-binding protein secretion from liver and accumulation in the kidneys of rats. J. Nutr., 123, 1497-1503
62. Ball, M. D., Furr, H. C., and Olson, J. A. (1985) Enhancement of acyl coenzyme A: retinol acyltransferase in rat liver and mammary tumor tissue by retinyl acetate and its competitive inhibition by N-(4-hydroxyphenyl)retinamide. Biochem. Biophys. Res. Commun. 128, 7-11
63. Dew, S. E., Wardlaw, S. A., and Ong, D. E. (1993) Effects of pharmacological retinoids on several vitamin A-metabolizing enzymes. Cancer Res. 53, 2965-2969
64. Törmä, H., Stenström, E., Anderson, E., and Vahlquist, A. (1991) Synthetic retinoids affect differently the epidermal synthesis of 3,4-didehydioretinol. Skin Pharmacol. 4, 246-253
65. Gabourel, J. D., Bradley, J. M. B., and Acott, T. S. (1990) Antagonism of retinol-induced RNA synthesis: assessment of retinoid toxicity in cultured retinal pigment epithelium. J. Toxicol. Cutaneous Ocul. Toxicol. 9, 251-263
66. Formelli, F., Carsana, R., Clerici, M., and Cleris, L. (1993) Pharmacological studies on fenretinide in breast cancer patients and in rats. In Retinoids. Progress in Research and Clinical Applications (Livrea, M. A., and Packer, L., eds) pp. 473-489, Marcel Dekker, Inc., New York
67. Lewis, K. C., Zech, L. A., and Phang, J. M. (1994) Effects of N-(4-hydroxyphenyl)retinamide supplementation on vitamin A metabolism. Cancer Res., 54, 4112-4117
68. Torrisi, R., Pensa, F., Orengo, M. A., Calsafados, E., Ponzani, P., Boccardo, F., Costa, A., and Decensi, A. (1993) The synthetic retinoid fenretinide lowers plasma insulin-like growth factor I levels in breast cancer patients. Cancer Res. 53, 4769-4771
69. Dillehay, D. L., Li, W., Kalin, J., Walia, A. S., and Lamon, E. W. (1987) In vitro effects of retinoids on murine thymus-dependent and thymus-independent mitogenesis. Cell Immunol. 107, 130-137
70. Dillehay, D. L., Walia, A. S., and Lamon, E. W. (1988) Effects of retinoids on macrophage function and IL-1 activity. J. Leukocyte Biol. 44, 353-360
71. Ross, A. C., Zhao, Z., Arora, D., Pasatiempo, A. M. G., Kinoshita, M., Gardner, E. M., Kantha, S. S., and Taylor, C. E. (1994) Retinoids in specific and nonspecific immunity: studies on antibody production and natural killer cells. In Retinoids: From Basic Sciences to Clinical Applications (Livrea, M. A., and Vidali, G., eds) pp. 197-213, Birkhauser, Basel
72. Villa, M. L., Ferrario, E., Trabattoni, D., Formelli, F., De Palo, C., Magni, A., Veronesi, U., and Clerici, E. (1993) Retinoids, breast cancer and NK cells. Br. J. Cancer 68, 845-850
73. McCarthy, D. J., Lindamood, C., III, Gundberg, C. M., and Hill, D. L. (1989) Retinoid-induced hemorrhaging and bone toxicity in rats fed diets deficient in vitamin K. Toxicol. Appl. Pharmacol. 97, 300-310
74. Kenel, M. F., Krayer, J. H., Merz, E. A., and Pritchard, J. F. (1988) Teratogenicity of N-(4-hydroxyphenyl)-all-trans-retinamide in rats and rabbits. Teratog. Carcinog. Mutagen. 8, 1-11
75. De Palo, G., and Formelli, F. (1995) Risks and benefits of retinoids in the chemoprevention of cancer. Drug Safety 13, 245-256
76. Decensi, A., Torrisi, R., Polizzi, A., Gesi, R., Brezzo, V., Rolando, M., Rondanina, G., Orengo, M. A., Formelli, F., and Costa, A. (1994) Effect of the synthetic retinoid fenretinide on dark adaptation and the ocular surface. J. Natl. Cancer Inst. 86, 105-110
77. Decensi, A., Bruno, S., Costantini, M., Torrisi, R., Curotto, A., Gatteschi, B., Nicoló, G., Polizzi, A., Perloff, M., Malone, W. F., and Bruzzi, P. (1994) Phase IIa study of fenretinide in superficial bladder cancer, using DNA flow cytometry as an intermediate end point. J. Natl. Cancer Inst. 86, 138-140
78. Gravallese, E. M., Handel, M. L., Coblyn, J., Anderson, R. J., Sperling, R. I., Karlson, E. W., Maier, A., Ruderman, E. M., Formelli, F., and Weinblatt, M. E. (1996) N-[4-hydroxyphenyl] retinamide in rheumatoid arthritis: a pilot study. Arthritis Rheum. 39, 1021-1026
79. Garewal, H. S., List, A., Meyskens, F., Buzaid, A., Greenberg, B., and Katakkar, S. (1989) Phase II trial of fenretinide [N-(4-hydroxyphenyl)retinamide] in myelodysplasia: possible retinoid-induced disease acceleration. Leuk. Res. 13, 339-343
80. De Palo, G., Veronesi, U., Camerini, T., Formelli, F., Mascotti, G., Boni, C., Fosser, V., Del Vecchio, M., Campa, T., Costa, A., and Marubini, E. (1995) Can fenretinide protect women against ovarian cancer? J. Natl. Cancer Inst. 87, 146-147
81. Tradati, N., Chiesa, F., Rossi, N., Grigolato, R., Formelli, F., Costa, A., and De Palo, G. (1994) Successful topical treatment of oral lichen planus and leukoplakias with fenretinide (4-HPR). Cancer Lett. 76, 109-111
82. Cobleigh, M. A., Dowlatshahi, K., Deutsch, T. A., Mehta, R. G., Moon, R. C., Minn, F., Benson, A. B., III, Rademaker, A. W., Ashenhurst, J. B., Wade, J. L., III, and Wolter, J. (1993) Phase I/II trial of tamoxifen with or without fenretinide, an analog of vitamin A, in women with metastatic breast cancer. J. Clin. Oncol. 11, 474-477
83. Kelloff, G. J., Crowell, J. A., Boone, C. W., Steele, V. E., Lubet, R., Doody, L. A., and Greenwald, P. (1994) Clinical development plan: N-(4-hydroxyphenyl) retinamide (4-HPR). J. Cell Biochem. 20, 176-196
84. Blaner, W. S., and Olson, J. A. (1994) Retinol and retinoic acid metabolism. In The Retinoids: Biology, Chemistry, and Medicine, 2nd Ed (Sporn, M. B., Roberts, A. B. and Goodman, D. S., eds) pp. 229-255, Raven Press, New York
85. Sass, J. O., Forster, A., Bock, K. W., and Nau, H. (1994) Clucuronidation and isomerization of all-trans and 13-cis retinoic acid by liver microsomes of phenobarbital- or 3-methylcholanthrene-trealed rats. Biochem. Pharmacol. 47, 485-492
86. Cenchi, G., Wang, W., Barua, A. B., Bidlack, W. R., and Olson, J. A. (1996) Formation of β-glucuronides and of β-galacturonides of various retinoids catalyzed by induced and noninduced microsomal UDP-glucuronosyltransferases of rat liver. Biochim. Biophys. Acta 1289, 284-290
87. Wang, W., Olson, J. A., and Bidlack, W. R. (1996) Characterization of rat microsomal retinoic acid UDP-glucuronosyltransferase isoenzyme using chromalofocusing. FASEB J. 10, A524 (abstr.)
88. Genchi, G., Barua, A. B., Wang, W., Bidlack, W. R., and Olson, J. A. (1996) pH profiles of retinoic UDP-glucuronosyl transferase activities (UDP-CT) in noninduced and 3-methylcholanthrene-induced rat liver microsomes. FASEB J. 10, A525 (abstr.)
89. Zile, M. H., Cullum, M. E., Simpson, R. U., Barua, A. B., and Swartz, D. A. (1987) Induction of differentiation of human promyelocytic leukemia cell line HL-60 by retinoyl glucuronide, a biologically active metabolite of vitamin A. Proc. Natl. Acad. Sci. USA 84, 2208-2219
90. Gallup, J. M., Barua, A. B., Furr, H. C., and Olson, J. A. (1987) Effects of retinoid β-glucuronide and N-retinoyl amines on the differentiation of HL-60 cells in vitro. Proc. Soc. Exp. Biol. Med. 186, 269-274
91. Sass, J. O., Elmazar, M. M. A., Thiel, R., Rühl, R., Plum, C., and Nau, H. (1995) Administration of all-trans retinoyl β-D-glucuronide to pregnant mice results in very low embryonic concentrations of the conjugate, but in exposure to teratogenic levels of its metabolite all-trans retinoic acid. Abstracts, Conference Retinoids '95, Sophia Antipolis, France, p. 97, CIRD GALDERMA, Sophia Antipolis, France
92. Urbach, J., and Rando, R. R. (1994) Isomerization of all-trans retinoic acid to 9-cis retinoic acid. Biochem. J. 299, 459-465
93. Coene, M. C., Dillen, L., Cools, W., Lejeune, L., Lauwers, W., and Van Wawe, J. (1995) 13-cis Retinoyl β-glucuronide and 4-keto-13-cis retinoyl β-glucuronide are natural retinoic acid metabolites in human urine. Abstracts, Conference Retinoids '95, Sophia Antipolis, France, p. 86, CIRD CALDERMA, Sophia Antipolis, France
94. Barua, A. B., and Olson, J. A. (1989) Method of producing water-soluble glucuronic acid derivatives of vitamin A. U.S. Patent Letters 4,855,463: Aug 8, 1989
95. Becker, B., Barua, A. B., Barua, M. and Olson, J. A. (1993) Relative effects of various carbohydrate conjugates of retinoic acid on the differentiation and viability of HL-60 cells. FASEB J. 7, A304 (abstr.)
96. Becker, B., Barua, A. B., and Olson, J. A. (1992) Cellular uptake and mode of action of retinoyl β-glucuronide. FASEB J. 6, A1660 (abstr.)
97. Mehta, R. B., Barua, A. B., Olson, J. A., and Moon, R. C. (1991) Effects of retinoid glucuronides on mammary gland development in organ culture. Oncology 48, 505-509
98. Olson, J. A., Moon, R. C., Anders, M. W., Fenselau, C., and Shane, B. (1992) Enhancement of biological activity by conjugation reactions. J. Nutr. 122, 615-624
99. Nau, H. (1993) Teratogenesis, transplacental pharmacokinetics, and metabolism of some retinoids in the mouse, monkey, and human. In Retinoids: Progress in Research and Clinical Application (Livrea, M. A., and Packer, L., eds) pp. 599-616, Marcel Dekker, New York
100. Sass, J. O., Seltmann, H., Rühl, R., Plum, C., Hettmannsberger, U., Orfanos, C. E., Nau, H., and Zouboulis, Ch. C. (1995) All-trans retinoic acid is more active in human keratinocyte cultures than its conjugate all-trans β-D-glucuronide. Abstracts, Conference Retinoids '95, Sophia Antipolis, France, p. 99, CIRD GALDERMA, Sophia Antipolis, France
101. Sani, B. P., Barua, A. B., Hill, D. L., Shih, T. W., and Olson, J. A. (1992) Retinoyl β-glucuronide: Lack of binding to receptor proteins of retinoic acid as related to biological activity. Biochem. Pharmacol. 43, 919-922
102. Mehta, R., Barua, A. B., Moon, R. C., and Olson, J. A. (1992) Interactions between retinoid β-glucuronides and cellular retinol-and retinoic acid-binding proteins. Int. J. Vitam. Nutr. Res. 62, 143-147
103. Takahashi, N., and Breitman, T. R. (1994) Retinoylation of proteins in mammalian cells. In Vitamin A in Health and Disease (Blomhoff, R., ed) pp. 257-273, Marcel Dekker, New York
104. Bovlan, J. F., and Cudas, L. J. (1991) Overexpression of the cellular retinoic acid binding protein-I (CRABP-I) results in a reduction in differentiation-specific gene expression in F9 teratorarcinoma cells. J. Cell Biol. 112, 965-979
105. Nau, H., Chahoud, I., Dencker, L., Lammer, E. J., and Scott, W. J. (1994) Teratogenicity of vitamin A and retinoids. In Vitamin A in Health and Disease (Blomhoff, R., ed) pp. 615-663, Marcel Dekker, New York
106. Cunning, D. B., Barua, A. B., and Olson, J. A. (1993) Comparative teratogenicity and metabolism of all-trans retinoic acid, all-irans retinoyl β-glucose, and all-trans retinoyl β-glucuronide in pregnant Sprague-Dawley rats. Teratology 47, 29-36
107. Barua, A. B., Batres, R. O., Gunning, D. B., and Olson, J. A. (1994) Reduction of serum retinol level in the rat after a single IP dose of all-trans retinoyl β-glucuronide or all-trans retinyl β-glucuronide. FASER J. 8, A444 (abstr.)
108. Cunning, D. B., Barua, A. B., Lloyd, R. A., and Olson, J. A. (1994) Retinoyl β-glucuronide: a nontoxic retinoid for the topical treatment of acne. J. Dermatol. Treat. 5, 181-185
109. Shealy, Y. F., Frye, J. L., and Schiff, L. J. (1988) N-(Retinoyl) amino acids. Syntheses and chemopreventive activity in vitro. J. Med. Chem. 31, 190-196